methotrexate has been researched along with Cancer of the Ureter in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (22.92) | 18.7374 |
1990's | 23 (47.92) | 18.2507 |
2000's | 5 (10.42) | 29.6817 |
2010's | 7 (14.58) | 24.3611 |
2020's | 2 (4.17) | 2.80 |
Authors | Studies |
---|---|
Fukami, N; Fukaya, K; Ichino, M; Kusaka, M; Nukaya, T; Sasaki, H; Shiroki, R; Sumitomo, M; Takahara, K; Takenaka, M; Zennami, K | 1 |
Barocas, DA; Bivalacqua, TJ; Black, PC; Cookson, MS; D'Andrea, D; Dall'Era, MA; Daneshmand, S; Dinney, CP; Holzbeierlein, JM; Kassouf, W; Lotan, Y; Matin, S; McGrath, JS; Morgan, TM; North, S; Petros, FG; Shariat, SF; Spiess, PE; Sridhar, SS; Stephenson, AJ; Thorpe, AC; van Rhijn, BW; Wright, JL; Zargar, H | 1 |
Asakuma, J; Asano, T; Hamada, S; Horiguchi, A; Ito, K; Kanbara, T; Tasaki, S; Tsujita, Y; Yoshii, H | 1 |
Kawamura, N; Matsushita, M; Nin, M; Okada, T; Tsujihata, M; Ujike, T | 1 |
Arima, K; Soga, N; Sugimura, Y | 1 |
Campbell, SC; Dreicer, R; Gong, MC; Hansel, DE; Lane, BR; Larson, BT; Raghavan, D; Smith, AK; Stephenson, AJ | 1 |
Cho, IC; Chung, J; Joung, JY; Kim, EK; Kwon, WA; Lee, KH; Park, S; Park, WS; Seo, HK; Yoon, H | 1 |
Kamoto, A; Kawashima, A; Nakai, Y; Nakayama, M; Nishimura, K; Nonomura, N; Ono, Y; Takada, T; Takayama, H; Tanigawa, G; Tsujimura, A; Ujike, T; Yamaguchi, Y | 1 |
Cordier, J; Sonpavde, G; Stief, CG; Tilki, D | 1 |
Igarashi, M; Kawaai, Y; Kitamura, H; Masumori, N; Shindo, T; Tamakawa, M; Tanaka, T; Tsukamoto, T | 1 |
Matsumura, K; Naganuma, T; Nakatani, T; Sugimura, K; Uchida, J | 1 |
Kawasaki, Y; Matsushita, M; Okada, Y | 1 |
Fukuda, H; Habuchi, T; Iinuma, M; Kato, T; Kumazawa, T; Minagawa, S; Mitsumori, K; Satoh, K; Satoh, S; Tadachi, K | 1 |
Blumenreich, M; Braun, DW; Natale, RB; Watson, RC; Whitmore, WF; Yagoda, A | 1 |
Chang, LS; Chen, KK; Chen, PM; Chiou, TJ; Hsieh, RK; Wei, CH | 1 |
Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
Akaza, H; Koiso, K; Miyanaga, N; Ohtani, M; Shimazui, T | 1 |
Igawa, M; Ishibe, T; Kadena, H; Shiina, H; Urakami, S; Usui, T | 1 |
Fujioka, H; Kishimoto, T; Kuroda, H; Makinose, S; Takatera, H; Tsujimoto, M; Yasunaga, Y | 1 |
Kawakami, M; Kobayashi, S; Niwakawa, M; Ogawa, A; Okaneya, T; Tsuruta, T | 1 |
Grossman, HB; Hamada, M; Koyanagi, T; Nonomura, K; Shinohara, N; Takakura, F | 1 |
Brunner, V; Bugat, R; Canal, P; Chatelut, E; Chevreau, C; Houin, G; Martinez, M | 1 |
Hosaka, M; Kondoh, K; Kubota, Y; Masuda, M; Misaki, H; Noguchi, S; Sakuramoto, T; Shuin, T; Yao, M | 1 |
Kobayashi, H; Obata, K | 1 |
Ishibe, T; Yamasaki, Y; Yokogi, H | 1 |
Kondoh, M; Miki, T; Nakamura, N; Nakano, E; Nishimura, K; Okuyama, A; Seguchi, T | 1 |
Amano, T; Hisazumi, H; Koshida, K; Kunimi, K; Morishita, H; Naito, K | 1 |
Blute, ML; Lerner, SE; Richardson, RL; Zincke, H | 1 |
Dimopoulos, C; Dimopoulos, MA; Giannopoulos, A; Karayiannis, A; Kostakopoulos, A; Kyriakakis, Z; Sofras, F; Zervas, A | 1 |
Miyagawa, Y; Oka, T; Satoh, E; Seko, M; Takaha, M; Takano, Y; Takeda, M; Tei, N; Tsujimura, A | 1 |
Fujii, J; Honda, J; Kikukawa, H; Kitani, K; Nakano, M; Nishi, K; Tokunaga, J; Ueda, S; Wada, Y | 1 |
Fujii, A; Higuchi, A; Ishikawa, J; Itoh, N; Murata, Y; Oka, N; Tanaka, H | 1 |
Kanai, S; Takagi, Y | 1 |
Jeffery, GM; Mead, GM | 1 |
Katayama, Y; Kawakami, Y; Kimura, M; Nishiyama, T; Osawa, T; Sasagawa, T; Sato, S; Tanikawa, T; Terunuma, M; Tomita, Y | 1 |
Akao, T; Hashimura, T; Nakagawa, T; Okumura, K | 1 |
Hatano, T; Hayakawa, M; Higa, I; Koyama, Y; Osawa, A; Shishido, S | 1 |
Akiyama, K; Sumiyoshi, Y; Yano, M | 1 |
Hida, S; Okada, K; Ooishi, K; Yamauchi, T; Yoshida, O | 1 |
Arakawa, S; Gohji, K; Kamidono, S; Matsumoto, O; Ohoka, H; Okada, H; Shimizu, T; Takenaka, A; Tatsumi, A | 1 |
Igawa, M; Ishino, T; Kume, T; Masu, C; Nakatsu, H; Ohnishi, Y; Okada, K; Ueda, M; Ueki, T; Usui, T | 1 |
Connolly, J; Gospodarowicz, M; Jewett, M; Tannock, I | 1 |
Bander, N; Geller, N; Herr, HW; Morse, MJ; Scher, HI; Sogani, PC; Sternberg, CN; Vaughan, ED; Watson, RC; Yagoda, A | 1 |
Fair, WR; Herr, HW; Morse, MJ; Reuter, V; Scher, HI; Sogani, PC; Sternberg, CN; Watson, RC; Whitmore, WF; Yagoda, A | 1 |
Kobayashi, K; Komatsu, H; Takihana, Y; Tanabe, N; Ueno, A | 1 |
Hisazumi, H; Kobashi, K; Nagano, K; Naito, K; Uchibayashi, T | 1 |
Ahmed, T; Geller, N; Herr, HW; Hollander, PS; Scher, HI; Sogani, PC; Sternberg, CN; Watson, RC; Weiselberg, LR; Yagoda, A | 1 |
Crocker, DW; Piro, AJ; Shirley, RL | 1 |
3 review(s) available for methotrexate and Cancer of the Ureter
Article | Year |
---|---|
Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Humans; Kidney Neoplasms; Kidney Pelvis; Methotrexate; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Treatment Outcome; Ureteral Neoplasms; Vinblastine | 2013 |
[Primary squamous cell carcinoma of the ureter: report of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Methotrexate; Middle Aged; Ureteral Neoplasms | 1993 |
[A case of primary right ureteral squamous cell carcinoma with intraperitoneal invasion].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Male; Methotrexate; Peritoneal Neoplasms; Ureteral Neoplasms; Vincristine | 1989 |
8 trial(s) available for methotrexate and Cancer of the Ureter
Article | Year |
---|---|
Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Risk Factors; Time Factors; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1996 |
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1994 |
The effect of dose intensity on M-VAC therapy for advanced urothelial cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Male; Methotrexate; Middle Aged; Survival Rate; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cell Count; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Neoplasms; Linear Models; Male; Methotrexate; Middle Aged; Neutropenia; Neutrophils; Thrombocytopenia; Ultrafiltration; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1995 |
[M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Colony-Stimulating Factors; Doxorubicin; Female; Gastrointestinal Diseases; Granisetron; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neutropenia; Recombinant Proteins; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1997 |
[M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Female; Humans; Japan; Kidney Neoplasms; Kidney Pelvis; Leukopenia; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Remission Induction; Thrombocytopenia; Ureteral Neoplasms; Vinblastine | 1989 |
37 other study(ies) available for methotrexate and Cancer of the Ureter
Article | Year |
---|---|
Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Nephroureterectomy; Proportional Hazards Models; Retrospective Studies; Sex Factors; Survival Rate; Ureteral Neoplasms; Vinblastine | 2021 |
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Comparative Effectiveness Research; Cystectomy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nephroureterectomy; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2021 |
[A CASE OF METASTATIC BLADDER UROTHELIAL CARCINOMA WHOSE DISEASE WAS CONTROLLED FOR A RELATIVE LONG PERIOD BY MULTIDISCIPLINARY TREATMENT INCLUDING RADIATION TO A LUNG METASTASIS AND MULTIPLE COURSES OF CHEMOTHERAPY].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Female; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Lung Neoplasms; Methotrexate; Neoplasm Invasiveness; Organ Sparing Treatments; Time Factors; Ureteral Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2017 |
[A case of effective neoadjuvant chemotherapy (MVEC) against right ureteral cancer involving bladder (cT4N1M0)].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Epirubicin; Humans; Male; Methotrexate; Neoadjuvant Therapy; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2014 |
Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Case-Control Studies; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nephrectomy; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2008 |
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Nephrectomy; Ureter; Ureteral Neoplasms; Vinblastine | 2010 |
Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Gentamicins; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Paclitaxel; Retrospective Studies; Treatment Failure; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urothelium; Vinblastine | 2011 |
The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cytarabine; Databases, Factual; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Nephrectomy; Prognosis; Proportional Hazards Models; Retrospective Studies; Ureteral Neoplasms; Vinblastine | 2012 |
A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Nephrectomy; Retrospective Studies; Survival Analysis; Ureter; Ureteral Neoplasms; Vinblastine | 2012 |
Advanced ureteral cancer with complete remission achieved by taxan containing systemic chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Neoplasms; Vinblastine | 2003 |
[Carcinomatous meningitis from urothelial carcinoma of bladder and ureter: case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Humans; Male; Meningeal Neoplasms; Meningitis; Methotrexate; Nephrectomy; Ureter; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2004 |
[Two cases of urothelial cancer responsive to high-dose-intensity methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Staging; Pulse Therapy, Drug; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2005 |
Methotrexate: an active drug in bladder cancer.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Prognosis; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1981 |
Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1995 |
[Optimal way of administration of granulocyte colony stimulating factor in the treatment of urological cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Testicular Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Expression of multidrug resistance gene product (P-glycoprotein) in transitional cell carcinomas of the upper urinary tract.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Female; Follow-Up Studies; Gene Expression; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Ureteral Neoplasms; Vinblastine | 1994 |
[M-VAC therapy in a patient with ureteral carcinoma accompanied by chronic renal failure].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Humans; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Renal Dialysis; Ureteral Neoplasms; Vinblastine | 1993 |
[MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Percutaneous mitomycin C perfusion of bilateral ureteral carcinoma in situ.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cisplatin; Doxorubicin; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Nephrostomy, Percutaneous; Time Factors; Ureteral Neoplasms; Vinblastine | 1993 |
Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Kidney Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Vinblastine | 1996 |
[A clinical study on renal pelvic and ureteral cancer--with special reference to prognostic factors and adjuvant chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Urologic Surgical Procedures; Vinblastine | 1998 |
[Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Female; Humans; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Renal Dialysis; Ureteral Neoplasms; Vinblastine | 2000 |
[Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Ureteral Neoplasms; Vincristine | 1992 |
[A case of CA19-9 producing transitional cell carcinoma of the ureter effectively responsive to combination chemotherapy].
Topics: Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Middle Aged; Tomography, X-Ray Computed; Ureter; Ureteral Neoplasms; Vinblastine | 1992 |
CMV chemotherapy for advanced transitional cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prostatic Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1992 |
[Sequential methotrexate and 5-fluorouracil, doxorubicin, and cisplatin for advanced urothelial cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1992 |
[Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Prognosis; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1991 |
[Early clinical result of modified M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of renal pelvis and ureter].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Remission Induction; Ureteral Neoplasms; Vinblastine | 1990 |
[A case of right renal pelvic and ureter cancer with hepatic metastasis showing complete response by M-VAC].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Humans; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Male; Methotrexate; Remission Induction; Ureteral Neoplasms; Vinblastine | 1990 |
[Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Cytarabine; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Methotrexate; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Peplomycin; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vincristine | 1985 |
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Kidney Neoplasms; Methotrexate; Middle Aged; Neutropenia; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1989 |
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1989 |
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urologic Neoplasms; Vinblastine | 1988 |
[A case of PN1 ureteral tumor with special reference to the significance of lymphadenectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Lymph Node Excision; Methotrexate; Middle Aged; Ureteral Neoplasms | 1987 |
[Successful chemotherapy with adriamycin and methotrexate in a case of advanced transitional cell carcinoma of the ureter--a clinical application of subrenal capsule assay].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Doxorubicin; Humans; Male; Methotrexate; Middle Aged; Subrenal Capsule Assay; Ureteral Neoplasms | 1987 |
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Radiotherapy Dosage; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1985 |
Malignant neural elements in a benign cystic teratoma. A case report.
Topics: Adult; Antineoplastic Agents; Bone Marrow Diseases; Cyclophosphamide; Dactinomycin; Dermoid Cyst; Female; Glioblastoma; Humans; Liver Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Ovarian Neoplasms; Radiography; Teratoma; Ureteral Neoplasms; Vincristine | 1971 |